← SynDRA
TOLIMIDONE
SynDRA canonical compound SYN0000248 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | SRC |
|---|
| Mechanism of action | Src activator |
|---|
All known targets
Mechanisms of action (all sources)
- SRC ACTIVATOR
- LYN POSITIVE ALLOSTERIC MODULATOR
- Tyrosine-protein kinase Lyn positive allosteric modulator
- LYN ACTIVATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- Tolimidona
- MLR-1023
- CP-26,154
- CP-26154
- NSC-314335
- Oral kinase activator (theraTRACE, oral, type 2 diabetes), Melior
- MLR 1023
- CP 26154
- 5-(3-methylphenoxy)-1H-pyrimidin-2-one
- 5-(3-methylphenoxy)-2(1h)-pyrimidinone
- MU3JD8E9IS
- NSC 314335
- RefChem:190291
- 5-m-Tolyloxy-pyrimidin-2-ol
- DTXCID90117277
- 5-(m-tolyloxy)pyrimidin-2(1H)-one
- 2(1H)-Pyrimidinone, 5-(3-methylphenoxy)-
- MFCD00866900
- MLR-1003
- Tolimidone (USAN)
- TOLIMIDONE [USAN]
- Tolimidone [USAN:INN]
- UNII-MU3JD8E9IS
- TOLIMIDONE [INN]
- Tolimidone (MLR-1023)
- TOLIMIDONE [WHO-DD]
- MLS006012600
- SCHEMBL637505
- GTPL9433
- orb1300367
- SCHEMBL21168610
- SCHEMBL31396447
- GLXC-02728
- HMS3749I15
- 5-(3-methylphenoxy)pyrimidin-2-ol
- EX-A1338
- RBA96407
- BDBM50545405
Look up TOLIMIDONE in the interactive SynDRA portal →